Filing Details
- Accession Number:
- 0001179110-12-007150
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-04-24 18:14:32
- Reporting Period:
- 2012-04-20
- Filing Date:
- 2012-04-24
- Accepted Time:
- 2012-04-24 18:14:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1327145 | L Robin Washington | Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94404 | Svp, Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-04-20 | 4,331 | $38.17 | 15,011 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-04-20 | 4,331 | $52.26 | 10,680 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-04-20 | 4,331 | $0.00 | 4,331 | $38.17 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
64,969 | 2021-01-20 | No | 4 | M | Direct |
Footnotes
- Pursuant to a Rule 105b-1 trading plan established by Ms. Washington on December 11, 2011.
- The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
- Sale prices reported for the transactions reported here range from $52.25 to $52.29. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.